Your browser doesn't support javascript.
loading
Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.
Perreault, Sylvie; Shahabi, Payman; Côté, Robert; Dumas, Stéphanie; Rouleau-Mailloux, Étienne; Feroz Zada, Yassamin; Provost, Sylvie; Mongrain, Ian; Dorais, Marc; Huynh, Thao; Kouz, Simon; Diaz, Ariel; Blostein, Mark; de Denus, Simon; Turgeon, Jacques; Ginsberg, Jeffrey; Lelorier, Jacques; Lalonde, Lyne; Busque, Lambert; Kassis, Jeannine; Talajic, Mario; Tardif, Jean-Claude; Dubé, Marie-Pierre.
Affiliation
  • Perreault S; Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.
  • Shahabi P; Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Quebec, Canada.
  • Côté R; Montreal Heart Institute, Montreal, Quebec, Canada.
  • Dumas S; Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.
  • Rouleau-Mailloux É; Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
  • Feroz Zada Y; Department of Neurology and Neurosurgery, Montreal General Hospital, Montreal, Quebec, Canada.
  • Provost S; Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.
  • Mongrain I; Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Quebec, Canada.
  • Dorais M; Montreal Heart Institute, Montreal, Quebec, Canada.
  • Huynh T; Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Quebec, Canada.
  • Kouz S; Montreal Heart Institute, Montreal, Quebec, Canada.
  • Diaz A; Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.
  • Blostein M; Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Quebec, Canada.
  • de Denus S; Montreal Heart Institute, Montreal, Quebec, Canada.
  • Turgeon J; Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Quebec, Canada.
  • Ginsberg J; Montreal Heart Institute, Montreal, Quebec, Canada.
  • Lelorier J; Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Quebec, Canada.
  • Lalonde L; Montreal Heart Institute, Montreal, Quebec, Canada.
  • Busque L; StatSciences Inc., Notre-Dame-de-l'Île-Perrot, Quebec, Canada.
  • Kassis J; Department of Medicine, Montreal General Hospital, Montreal, Quebec, Canada.
  • Talajic M; Département de médecine spécialisée, Centre hospitalier régional de Lanaudière, Joliette, Quebec, Canada.
  • Tardif JC; Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.
  • Dubé MP; CIUSSS-MCQ, Université de Montréal, Campus Mauricie, Trois-Rivières, Quebec, Canada.
Clin Cardiol ; 41(5): 576-585, 2018 May.
Article in En | MEDLINE | ID: mdl-29542828
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Warfarin / Blood Coagulation / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Clin Cardiol Year: 2018 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Warfarin / Blood Coagulation / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Clin Cardiol Year: 2018 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos